Articles tagged with Immune Response
The RV144 vaccine has shown promising results with a new study indicating it may provide protection against multiple strains of HIV. Researchers discovered that the vaccine elicited stronger immune responses, particularly in men, and was well-tolerated, suggesting potential long-term efficacy.
The study reveals that ectosomes, tiny vesicles containing key immune messages, can be intercepted and deciphered using super resolution microscopy. This breakthrough understanding of cellular communication has significant implications for developing therapies that shape the immune response to specific diseases.
A study by Emory Vaccine Center and CDC found immunity against mumps virus insufficient in a fraction of college-aged people who received MMR as children. The results highlight the need for better understanding of immune response to mumps and vaccines.
A team of biologists has shed new light on a crucial aspect of the plant immune response, revealing how plant resistance proteins trigger localized cell death. By understanding this mechanism, scientists may develop strategies for engineering disease-resistant crops.
A new chlamydia vaccine has shown promising early signs of effectiveness in a phase 1 clinical trial, provoking an immune response in all participants. The vaccine, CTH522, demonstrated improved performance with added liposomes, producing higher antibody levels and a more consistent cell-mediated immune response.
A new study suggests that nitazoxanide, an FDA-approved anti-parasitic drug, could potentially treat Ebola by enhancing the immune system's ability to detect the virus. The drug inhibited Ebola replication and worked by broadly amplifying the interferon pathway and cellular viral sensors.
A PSU biologist is investigating the link between a Western diet high in fat and sugar and its effects on the immune system, with a focus on chronic inflammation and sepsis severity. The researcher aims to identify molecular mechanisms behind this relationship and explore potential dietary interventions.
A study found that women's immune response to the flu vaccine is stronger than men's, but declines with age, especially in women. Researchers discovered that estrogen levels boost female immunity, while testosterone has a weaker effect on male responses.
A new study published in The Plant Cell found that plant immune systems vary between species, contradicting previous assumptions based on Arabidopsis thaliana research. Researchers used CRISPR/Cas9 genome editing techniques to investigate the tobacco plant Nicotiana benthamiana's immune response.
The approach demonstrated in mice enhances healing by reprogramming aggressive immune cells to work for the body, reducing inflammation and promoting regeneration. This technology could lead to new therapeutic strategies for patients with spinal cord injury and inflammatory diseases.
A recent study published in Proceedings of the National Academy of Sciences shows that mosquitoes employ a multi-stage immune response to combat malaria parasites, involving a complement-like pathway and phenoloxidases. This understanding could lead to opportunities to eliminate malaria parasites in the mosquito, reducing human cases.
Female bed bugs exhibit induced antibacterial humoral immune responses when fed regularly, with a 22% increase in longevity compared to unpredictable feeding schedules. Anticipation of mating-associated infection through feeding cues may influence reproductive immune anticipation.
Researchers at St. Jude Children's Research Hospital found that children with acute lymphoblastic leukemia mount a robust immune response to their cancer. The study suggests that the immune system may be able to effectively target pediatric ALL, potentially leading to new immunotherapy treatments.
Researchers studying CD73, an enzyme suppressing the natural immune response, hope to block its production to help treat aggressive head and neck cancers. High levels of CD73 are associated with poor prognosis in these cancers.
Researchers developed a novel mouse model of intestinal parasite infection that mimics human disease, offering protection against Cryptosporidium infection. The model uses a naturally occurring species of mouse Cryptosporidium and demonstrates the importance of T cells and interferon-gamma in immune response.
Dr. Julie Marchesan, a rising young researcher, is the recipient of the $10,000 AADR Anne D. Haffajee Fellowship to support women in oral biology research. The fellowship aims to increase female representation in science and academia.
Researchers identified Roseburia intestinalis as a gut bacterium triggering antiphospholipid antibodies in patients with antiphospholipid syndrome. The study suggests that eliminating this bacterium may help decrease antibody levels and open doors for future treatment options.
Scientists studying Leishmania parasites found that they can mate to produce hybrid offspring carrying genetic material from multiple strains, suggesting a true sexual reproductive cycle. This discovery could lead to improved treatment for deadly Leishmaniasis infections.
A new study by immunologists at the Babraham Institute has shown that fecal transplants from young mice can replenish and boost the gut microbiome of older mice, rejuvenating their immune system. The research suggests that targeting the gut microbiome could be a way to treat age-related symptoms and facilitate healthy aging.
A new method using flow cytometry has been developed to measure the immune response in islet transplant recipients. This standardized approach helps predict patient outcomes and could enable early intervention to prevent rejection.
A new study from Rockefeller University reveals that the gut is organized into compartments with different immune system functions in each segment. This discovery has potential to improve drugs for gastrointestinal disorders and inform the development of oral vaccines.
New research at the University of Sheffield reveals that dead cells can disrupt the normal function of immune cells, called macrophages, which are crucial for responding to wounds and patrolling for infection. The study's findings could lead to new therapies to manipulate white blood cells and accelerate healing processes.
Researchers found that Ebola survivors developed high levels of neutralizing antibodies months after recovery, which could inform the design of antiviral therapies and vaccines. The study's findings have implications for understanding immune protection after vaccination and developing effective treatments.
Scientists at La Jolla Institute for Immunology developed a new HIV vaccine delivery strategy that enhances the protective immune response by slowly releasing vaccine doses. This approach, called escalating dose strategy, leads to stronger and more neutralizing antibodies against the virus.
Researchers at Swansea University's Medical School have found that immune cells can re-programme their metabolic pathways to provide energy and building blocks when challenged. This discovery suggests that manipulating metabolism could lead to new therapies for infectious diseases and cancer.
Researchers at Northwestern University have designed spherical nucleic acids (SNAs) that stimulate powerful anti-cancer immune responses, completely eliminating tumors in 30% of animals and improving overall survival. The study's findings highlight the importance of chemical structure and three-dimensional presentation in vaccine design.
Researchers have identified a key enzyme that helps cancer cells survive by eliminating junk RNA. Targeting this enzyme, ADAR, may lead to breakthroughs in treating various types of cancer.
Researchers found that combining tumor-selective angiotensin blockers with immune checkpoint blockers significantly improves breast cancer treatment in mouse models. The combination treatment normalizes the tumor microenvironment, inducing changes in gene expression and activating immunosupportive pathways.
Researchers at the La Jolla Institute for Immunology discovered that genetic deletion of TET2 and TET3 in mouse B cells impairs the generation of functional IgG antibodies, highlighting the critical role of epigenetic control in healthy immune cell function.
A small clinical trial shows that gene therapy can safely correct the immune systems of infants with X-SCID, a rare life-threatening disorder. The treatment involves inserting a normal copy of the IL2RG gene into the patient's blood-forming stem cells.
A recent study published in The Gerontologist suggests that the link between caregiving and negative health effects has been overstated. After analyzing data from over three decades of research, Johns Hopkins researchers found a weak association between caregiving and immune system biomarkers.
A study suggests that tert-butylhydroquinone (tBHQ) impairs immune function and makes flu shots less effective in mice. The findings could explain why seasonal influenza poses a major global health threat.
Researchers discovered that owl monkey cytomegalovirus produces a CD48 decoy receptor called A43, which binds strongly to natural killer cells and blocks their interaction with CD48. This finding highlights the potential of using A43 as a therapeutic tool to manipulate aberrant immune responses.
Researchers have discovered a highly focused antibody response in dengue infection that neutralizes the virus and persists for months. The study provides new insights into the complex immune response to dengue and could lead to advanced vaccine formulations.
Researchers found a class of enzymes called metacaspases play a crucial role in plant immune response, releasing calcium and peptides to prevent infection. The discovery opens up new avenues for improving crop breeding techniques and boosting plant immunity.
Researchers investigate the conditions that drive protein droplets to switch from a fluid to a gel-like state, finding that environmental factors play a crucial role. The study uses innovative techniques such as optical tweezers and laser poking to probe the dynamics of these tiny molecules, which may be involved in health and disease.
A novel mechanism discovered by researchers at the University of York and Queen Mary University London reveals that miR-132 controls how immune cells respond to infection. This tiny molecule acts as a 'handbrake' on the immune system, preventing over-reaction and promoting protective immunity.
Researchers develop TIGER mouse to track information-rich particles in brain, revealing new cell types releasing extracellular vesicles. The study aims to generate an atlas for diagnosing and treating various diseases.
A high-fat diet and aging are associated with inflammation in heart failure, as well as changes to the gut microbiome. In mice, a calorie-dense diet altered the composition of the gut microbiome and increased neutrophils, leading to nonresolving inflammation.
New research from UNC School of Medicine reveals that tick bites can cause an allergic immune response to alpha-gal, a sugar found in most mammal blood except humans, leading to red meat allergy syndrome (AGS). This challenges previous theories and suggests the risk of each tick bite may be higher than anticipated.
A mouse model study published in The FASEB Journal suggests that gastrointestinal neuroimmune disruption is a contributing mechanism of Gulf War Illness. The research found that exposure to pyridostigmine bromide causes long-lasting gastrointestinal issues and immune system changes in the gut and brain.
Researchers at Duke University found that a single CRISPR treatment can safely correct genetic disease for over a year, despite immune responses. The study suggests approaches to address potential challenges and potentially deliver the therapy to infants or restrict Cas9 expression.
EDS1 protein partners with PAD4 and SAG101 to promote reprogramming of gene expression and localized cell death, carrying out a crucial link between recognition and resistance in plant immunity. A key surface on EDS1 enables its functions, promoting salicylic acid accumulation and blocking bacterial virulence molecules.
Two clinical studies show that liquid biopsies can accurately track lung cancer treatment responses, detecting changes in circulating tumor DNA four weeks earlier than CT imaging. The tests provide a more accurate and noninvasive way to assess therapeutic responses, avoiding unneeded toxicity or ineffective treatments.
Researchers found that self-compassion exercises calmed the heart rate and reduced stress responses in healthy individuals. This approach has been linked to improved mental health outcomes and may be beneficial for people with depression. Future studies aim to investigate this method further.
Researchers found that lizards from high-stress environments had more robust immune systems when exposed to prolonged stress, suggesting a potential adaptive advantage. The study's results may have implications for human stress response and disease prevention.
Research highlights the importance of tumor-associated Tregs in evoking effective antitumour immune responses. Depletion or inhibition of Tregs may enhance antitumor effects, suggesting a promising strategy for alleviating tumour immunesuppression and improving immune responses against cancers.
A new study of twins found that genetic factors significantly impact the body's immune defense networks. The researchers analyzed blood samples from 1835 twins and thousands of siblings to understand how effectively their bodies deploy disease-fighting molecules.
Genetic variations in metallothionein and zinc transporter genes impact zinc homeostasis and immune function. SNPs may influence the response to zinc supplementation in individuals with certain non-communicable diseases.
TGF-β1 is a potent modulator of immune and glial cell functions, regulating processes like fibrosis, atrophy, and muscle regeneration. Researchers discuss therapeutic strategies to inhibit the deleterious actions of TGF-β1 in skeletal muscle.
Researchers have developed techniques to personalize anticancer vaccines based on individual patient genomic information, targeting unique tumor mutations. Early results show promise in inducing potent immune responses.
Researchers found that certain E. coli strains trigger protective immune responses while others evade them, leading to recurrent infections. The study suggests developing broad-spectrum vaccines should consider the diverse pathogens encountered in the community.
Researchers at Scripps Research have identified a crucial immune system-regulating protein called ABHD12, which is linked to a rare genetic disease featuring brain and nerve problems. The study suggests that targeting ABHD12 may offer new avenues for treating cancers and chronic viral infections.
Researchers develop method to identify tumor-specific factors in blood that can elicit a protective immune response, potentially leading to an effective vaccine against cancer. The technique relies on peptide arrays and frameshift mutations, which have been shown to be more effective stimulators of immune response than point mutations.
Researchers designed a quadrivalent fusion glycoprotein vaccine against human parainfluenza viruses, inducing up to 500-fold higher neutralizing immune responses. The shape-stabilized glycoproteins may offer a general class of vaccines against widespread parainfluenzas and related pathogens.
A study published in PNAS found that the Mincle receptor initiates an antibacterial response to Group A Streptococcus upon recognition of MGDG, an anchor of lipoteichoic acid. The receptor plays a critical role in the immune response to GAS and may provide a therapeutic option by increasing antibacterial immunity.
Researchers have identified a cellular target that may improve vaccine efficacy in immunocompromised individuals, who are highly susceptible to fungal infections. The study found that targeting CBLB, a protein important in regulating immune response, can elicit immunity through a unique T cell pathway.
Research discovered that actin cytoskeleton remodeling in breast cancer cells protects them from immune cell attack by limiting the transfer of cytotoxic proteins. The 'actin response' is associated with increased levels of immune-inhibitory ligands, rendering cancer cells resistant to NK cell-mediated cytotoxicity.
A new study by CNIC researchers reveals that immune cells like neutrophils help maintain normal function of healthy tissues, performing roles unrelated to immunity. The findings suggest that the immune system is essential for day-to-day health, with potential benefits in some tissues and risks in others.
Targeting immune checkpoints in microglia may reduce neuroinflammation in neurodegenerative diseases. Dysregulation of these checkpoints is linked to diseases such as Alzheimer's, Parkinson's, and ALS.